ATAI Life Sciences BV (ATAI) Stock Forecast & Price Target
ATAI Life Sciences BV · NASDAQ
$7.17-0.01 (-0.07%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 9 firms covering ATAI Life Sciences BV, 2 rate it Buy or better, 7 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets range widely, $7.50 to $16.00 (about 2.1x), a sign of real disagreement on valuation. The average target of $11.88 sits 66% above the current $7.17. The rating mix has stayed broadly stable, with Buy-side ratings easing from 7 to 1 over recent months. On the fundamentals, the Street sees revenue growth near -88% this year and -57% next, consensus EPS building from about $-0.12 next quarter toward $-0.46 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS9 ratings
Hold
Strong Buy00%
Buy222%
Hold778%
Sell00%
Strong Sell00%
Based on 9 analysts giving stock ratings to ATAI Life Sciences BV.
As of Jul, 1 of 8 firms rate ATAI a Buy (7 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ATAI EPS & revenue forecast
EPS · NEXT QUARTER
$-0.12
Range $-0.21 – $-0.08 · 9 analysts · -57% YoY
Next period, 9 analysts expect ATAI Life Sciences BV to earn $-0.12 a share (range $-0.21 – $-0.08), versus $-0.28 a year earlier. Full-year consensus is $-0.43, growing to $-0.46 the year after.
REVENUE · NEXT QUARTER
$83.3K
Range $0 – $900.0K · 9 analysts · -87% YoY
Revenue is expected to reach $83.3K (range $0 – $900.0K), -87.0% year-over-year. Full-year consensus is $1.1M, rising to $218.2K next year.
Top analysts covering ATAI Life Sciences BV
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ATAI.
#1
Ami Fadia
Needham · Rank #90
Hold
No targeton ATAI
Overall win rate
46%
+ Follow
#2
Patrick R. Trucchio
HC Wainwright & Co. · Rank #203
Hold
$7.50+4.5% to target
Overall win rate
35%
+ Follow
#3
PS
Pete Stavropoulos
Cantor Fitzgerald · Rank #232
Hold
No targeton ATAI
Overall win rate
34%
+ Follow
#4
Sumant Kulkarni
Canaccord Genuity · Rank #278
Hold
$8.00+11.5% to target
Overall win rate
39%
+ Follow
#5
Jay Olson
Oppenheimer · Rank #302
Buy
$16.00+123.0% to target
Overall win rate
32%
+ Follow
ATAI stock forecast FAQ
What is ATAI's average 12-month price target?+
The 5 analysts with a live target average $11.88 for ATAI Life Sciences BV over the next 12 months, ranging from a $16.00 high to a $7.50 low.
Is ATAI stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 9 analyst ratings, 2 are Buy or Strong Buy, 7 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ATAI?+
The Street-high target is $16.00, and the Street-low is $7.50 (HC Wainwright & Co.). The average of all 5 active targets is $11.88.
How many Wall Street analysts cover ATAI?+
9 analysts have an active rating on ATAI Life Sciences BV, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering ATAI?+
Among analysts who currently cover ATAI, Ami Fadia of Needham has the strongest overall Quantellect track record (Rank #90). Their current call is Hold.
What is ATAI Life Sciences BV's projected EPS for next quarter?+
The consensus estimate is $-0.12 per share (range $-0.21 – $-0.08) across 9 analysts. Full-year EPS is projected at $-0.43, rising to $-0.46 the following year.
How much revenue is ATAI Life Sciences BV expected to report next quarter?+
Consensus revenue is $83.3K (range $0 – $900.0K). Full-year revenue is projected at $1.1M, growing to $218.2K next year.
Have analysts been upgrading or downgrading ATAI lately?+
As of Jul, 1 of 8 firms rate ATAI a Buy (7 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ATAI calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
